Lite Strategy (LITS) Treasury Shares (2020 - 2026)

Lite Strategy (LITS) posted quarterly Treasury Shares of $1.6 million for Q1 2026, up 1280.43% quarter-over-quarter from -$138000.0 in Q4 2025.

Lite Strategy (LITS) Treasury Shares (2020 - 2026) Analysis & Trends

Lite Strategy's Treasury Shares history runs 2 years deep, the most recent figure standing at $2.0 million for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	2.72 Mn
10	Lite Strategy	35.71 Mn	28.17 Mn	-	1.63 Mn

Download Data